Guggenheim Raises Praxis Precision Medicines Price Target to $1,050
The large target increase is a bullish analyst signal, but the unusually high target warrants caution.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The large target increase is a bullish analyst signal, but the unusually high target warrants caution.
What happened, with direct paths to the underlying reporting
Guggenheim raised its price target on PRAX to $1,050; the posted price was $328.13. The target implies substantial upside, though it is an analyst opinion rather than a guarantee.
Target: $1,050
Posted price: $328.13
Analyst firm: Guggenheim
Analyst: Yatin Suneja
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.